Background. To examine the time trend and international differences in access to the waiting list and renal transplantation of patients with end-stage kidney disease. Methods. We included all patients (n = 30 961) from Austria, Norway, the Netherlands and Scotland who started renal replacement therapy (RRT) between 1995 and 2003 with their kidney transplant waiting list data (until 31 December 2005) and follow-up data on RRT and mortality (until 31 December 2007). The outcome measure was access to the waiting list within 2 years and to a first renal transplant within 4 years from the start of RRT, expressed as incidence per million age-related population ( p.m.a.r.p.) per year. To estimate trends over time, mean percentage annual change (MPAC) and 95% confidence interval (CI) were calculated. Results. In each country, the number of patients starting RRT > 65 years increased significantly over time, whereas the number of renal transplants did not increase to the same extent. Only in Norway were almost all patients on the waiting list transplanted within 4 years of RRT start if they were < 65 years. In patients who started RRT > 65 years, the access to renal transplantation was high in Norway (49 p.m.a.r.p.) and low in Austria ( < 26 p.m.a.r. p.), the Netherlands and Scotland (both < 10 p.m.a.r.p.) but increased significantly in Austria (MPAC = 9.8%; 95% CI = 3.9-16.9) and the Netherlands (MPAC = 9.0%; 95% CI = 3.2-15.0). Conclusion. Only in Norway, virtually all patients on the waiting list < 65 years received a transplant within 4 years after the start of RRT and, remarkably, also most of those > 65 years of age.
Introduction
Renal transplantation is considered the best renal replacement therapy (RRT) for patients with end-stage kidney disease (ESKD) [1, 2] . The notion is widely held that patients who receive a renal transplant have a better quality of life and better survival than those on dialysis [1, 2] . In addition, the costs of transplantation appear to be less than those of dialysis [2, 3] . It is therefore important for policy makers and health administrators to implement strategies to increase the rate of kidney transplantation from deceased and living donors [4] [5] [6] .
Within the European Union, ∼360 000 patients are currently receiving RRT, and only about one-third of them are living on a functioning graft [7] [8] [9] . Moreover, the number of patients who need RRT has increased rapidly over the last 10 years, and is still increasing [7, 8, 10] , whereas data from annual reports show that the number of renal transplants has not increased to the same extent [11, 12] . Little is known, however, about the time trend in the likelihood of accessing the kidney transplant waiting list for patients needing RRT [11] and in the likelihood to eventually receiving a kidney transplant. This is the first large European study designed to examine the time trend and international differences in access to the waiting list and renal transplantation of patients with ESKD. Such a study is necessary to show the extent to which different health care systems meet the need for renal transplantation and how successful they are in facilitating kidney transplantation from either deceased or living donors.
Materials and methods

Data collection
Individual patient data from both incident and prevalent patients who were on RRT between 1995 and 2007 were obtained from the ERA-EDTA Registry database [13] .
Since the ERA-EDTA Registry routine data collection does not include information on the waiting list for kidney transplantation, European national and regional renal registries and transplant organizations were asked to provide the date of the first access to the kidney transplant waiting list for patients who started dialysis between 1 January 1995 and 31 December 2005. These data were provided by Austria and the Netherlands (from Eurotransplant), Norway (from local transplantation centre data) and Scotland (from the Scottish Renal Registry). Only patients who were resident in the participating countries at the start of RRT were included in the study. We assigned a waiting list time of 1 day to subjects who received a pre-emptive transplant or a transplant from a living donor without entering a waiting list.
Analyses Descriptive statistics
Incidence and prevalence of RRT. For each participating country, the unadjusted incidence and prevalence of RRT per million age-related population (p.m.a.r.p.) was examined for each year from 1995 to 2007. The unadjusted RRT incidence p.m.a.r.p. was defined as the number of new patients on RRT in a year per age group (e.g. ≥ 65 years of age) divided by the mid-year general population in that age group. The unadjusted prevalence of RRT p.m.a.r.p. was defined as the number of patients receiving RRT on 31 December of each year per age group divided by the mid-year general population in that age group.
Performed transplants. For each country, the number of performed transplants per million population ( p.m.p.) was examined for each year from 1995 to 2007 for all age groups together. The number of performed transplants p.m.p. per year was defined as the number of transplants performed in a year divided by the mid-year general population.
Primary outcome measures
Access to waiting list and renal transplantation. Figure 1 shows which patients were included in the different statistical analyses to examine the time trend in access to the waiting list and to a first renal transplant from the start of RRT. Of the patients who started RRT between 1995 and 2003, we examined how many of them (expressed as incidence p.m.a.r.p. per year) were (i) on the waiting list, (ii) on dialysis but not on the waiting list or (iii) dead without entering the wait listing 'within 2 years after the start of RRT'. Furthermore, of the patients who were on the waiting list within 2 years, we examined for each year how many of them (expressed as incidence p.m.a.r.p.) were (i) transplanted with a living or deceased donor kidney, (ii) remained on dialysis without transplantation or (iii) died without receiving a transplant 'within 4 years after the start of RRT'. The analyses were repeated by primary renal disease group (diabetes mellitus Type I, diabetes mellitus Type II, hypertension, renal vascular disease, glomerulonephritis, pyelonephritis, polycystic kidneys adult type and other) and by sex. Using this stepwise approach, our results on access to renal transplantation may not reflect all transplants performed, partly because our analyses on access to transplantation include only the first transplants in patients from the start of RRT.
Secondary outcome measure
Waiting time. For the patients who received a renal transplant, the median time from the date of RRT start until the date the patient received this transplant was calculated in months (median transplant waiting time). Analyses were stratified by year of dialysis initiation (from 1995 to 2003) and country. As we had no information on the date of removal from the waiting list, the waiting times may be overestimated.
Estimation of trend. The time trend for each descriptive statistics and primary and secondary outcome measures was estimated using Poisson regression, with the observed rate as outcome and year as explanatory variable. The mean percentage annual change (MPAC) and its 95% confidence interval (CI) were computed from each model as [exp(β) − 1] × 100, where β denotes the regression coefficient of time (i.e., change in the event rate per unit time).
As it is less common for patients > 65 years to be on the kidney transplant waiting list [14, 15] , we present data separately for patients below and above this age limit, unless indicated otherwise.
Results
Incidence and prevalence of RRT Table 1 shows the baseline characteristics of the patients who started RRT in Austria, Norway, the Netherlands and Scotland between 1995 and 2007 and the corresponding general population base. In the 1990s, the majority of the patients started RRT when they were < 65 years, whereas in more recent years, in Austria, Norway and the Netherlands, the majority of the patients who started RRT were > 65 years. The percentage of patients with diabetes mellitus Type II as primary renal disease was by far highest in Austria. Table 2 shows that in all participating countries, the RRT incidence p.m.a.r.p. > 65 years increased tremendously over time. Austria had the highest incidence rates in both age groups. Norway had the lowest rates among those < 65 years, whereas the lowest rates among people > 65 years were observed in Norway until 2005 and in Scotland in 2006 and 2007. Figure 2 shows that the RRT prevalence p.m.a.r.p. increased in each country both in the age groups under and above 65 years, but the increase was more evident in this second group. Figure 2 also shows that of all prevalent patients on RRT in each country, Norway had the highest proportion of patients who were living on a functioning graft and consequently, the lowest proportion of patients undergoing dialysis. Access to the waiting list and renal transplantation 3623 of the transplant rates from living donors increased significantly over time in countries where rates were lower in the 1990s (Austria, the Netherlands and Scotland).
Access to the waiting list for patients <65 years
In patients who started RRT < 65 years of age, the proportion of patients on the waiting list 2, 3 and 4 years after the start of RRT was 57.4, 59.6 and 60.5%, respectively. These proportions were 3.8, 3.0 and 2.9% higher in patients starting RRT from 1995 to 1998 compared to those who started RRT from 1999 to 2003. Figure 4a shows the time trend in access to the waiting list in patients <65 years. In this age group, there was no statistically significant change in access to the waiting list from 1995 to 2003 in Austria, Norway and the Netherlands. In Scotland, access to the waiting list declined from 40.1 to 32.8 p.m.a.r.p. [MPAC −2.7 (95% CI: −4.7 to −0.6)].
Norway and Austria had only a slightly higher access to the waiting list as compared to the Netherlands and Scotland. However, in Norway, almost 80% of the patients starting RRT < 65 years were on the waiting list, whereas this was the case to a lesser extent in other countries. In all countries, of those starting dialysis within 2 years without being waitlisted, ∼40% died.
Access to renal transplantation for patients <65 years
Figure 4b includes patients < 65 years who were placed on the waiting list within 2 years of RRT start (i.e., the dark bars in Figure 4a ). It can be seen that although the number of transplants p.m.a.r.p. from living donors increased significantly over time in Austria, the Netherlands and Scotland, the total number of transplants p.m.a.r.p. did not change in Austria and the Netherlands, whereas it decreased in Scotland. Figure 4b also shows that only in Norway, almost all patients who were on the waiting list were also transplanted within 4 years after the start of RRT. Although Norway achieved a greater number of transplants in total and from living donors, Austria had the highest number of transplants from deceased donors.
Access to the waiting list for patients >65 years
In patients who started RRT > 65 years of age, the proportion of patients on the waiting list 2, 3 and 4 years after the start of RRT was 8.0, 8.5 and 8.6%, respectively. These proportions were 0.6, 0.4 and 0.3% higher in patients starting RRT from 1995 to 1998 compared to those who started RRT from1999 to 2003. Figure 5a shows the time trend in access to the waiting list p.m.a.r.p. in patients starting RRT >65 years. Although within each country, the total incidence p.m.a.r.p. of RRT increased significantly over time in this age group, there was only a slight or no increase at all in the incidence p. m.a.r.p. of patients on the waiting list.
Within the oldest age group, the proportion of patients on the waiting list was highest in Norway (24%), whereas this was ∼6% in the other countries. In all countries, ∼40-50% of patients starting RRT >65 years died within 2 years after the start of RRT without being waitlisted.
Access to renal transplantation for patients >65 years
Figure 5b includes patients who started RRT >65 years and were on the waiting list within 2 years after the start of RRT (i.e., the dark bars in Figure 5a ). Since this patient cohort is only a small proportion of the total incidence p.m.a.r.p., the range of the y-axis in Figure 5b In Austria, the Netherlands and Scotland, the access to transplantation for patients > 65 years was low and depended mainly on the availability of deceased donor kidneys. Nevertheless, the overall access to transplantation increased modestly but significantly over the period in Austria and The Netherlands. The incidence p.m.a.r.p. and the proportion of patients receiving a renal transplant from a living or deceased donor within 4 years were by far the highest in Norway (49 p.m.a.r.p., 76%). 
Subgroup analyses
In all participating countries, access to the waiting list and renal transplantation was rare in patients with diabetes mellitus Type II as primary renal disease, whereas access did not differ between men and women. In patients who started RRT both below and above 65 years of age, access to the waiting list p.m.a.r.p. and renal transplantation p.m.a.r.p. was highest in Norway for patients with glomerulonephritis, pyelonephritis, hypertension and polycystic kidney disease adult type as primary renal disease, whereas this was highest in Austria for patients with diabetes mellitus Type II as primary renal disease.
Waiting time Figure 6 shows that for patients on the waiting list, the median transplant waiting time was shortest in Norway (range 6-11 months). Please note that we assigned a Access to the waiting list and renal transplantation 3627
waiting list time of 1 day to subjects who received a preemptive transplant or a transplant from a living donor without entering a waiting list. Additional analysis showed that patients in the Netherlands needed to wait longer for a transplant from a living donor than those in Norway, which was partly due to the higher proportion of pre-emptive transplants from living donors in Norway (35% of all living donors) compared to the Netherlands (5%). Only in Austria did we observe a decrease in the median transplant waiting time.
Discussion
This is the first large European study investigating the time trend and international differences in access to the waiting list and renal transplantation. The main strength of this study is that it included all patients starting RRT and their waiting list data over > 10 years in four European countries. The results of this study indicate that the time trend in access to the waiting list and renal transplantation mainly changed in patients who started RRT > 65 years. In particular, although the number of patients starting RRT in the older age group increased tremendously over time, the number of renal transplants has not increased to the same extent. Importantly, with the exception of Norway, the health care systems did not meet the need for renal transplantation in both patients below and above 65 years. Further efforts are needed to improve access to renal transplantation from deceased and living donors. This study shows that different national policies may result in international differences in access to the waiting list and renal transplantation and could therefore facilitate the identification of opportunities to improve the number of renal transplantations.
Access to the waiting list
The increase in RRT incidence over time in patients > 65 years mainly included patients who were not put on the waiting list. This finding may suggest an increase in older and 'sicker' patients starting RRT who were potentially not suitable for transplantation [16, 17] . However, we cannot rule out the possibility that elderly patients who meet the eligibility criteria for transplantation are not offered access to the waiting list because their physicians may feel that their likelihood to receive a graft before they die may be too low.
To our knowledge, no studies were performed on reasons for differences in access to the waiting list between countries; however, several national studies examined reasons for differences in access to the waiting list between centres [14, 15, 18] . Results of studies from France [14] and the UK [15, 18] showed that patient characteristics, such as psychiatric disorders, cardiovascular disease, diabetes, a past history of malignancies, physical impairment and being white or socially deprived, were associated with non-registration on the kidney transplant waiting list. Additionally, the French study showed that irrespective of patient characteristics, treatment in a non-transplant centre was independently associated with non-registration on the kidney waiting list [14] , a finding not confirmed by the UK data [15] . In our study, we found that the incidence of RRT for ESKD due to diabetes mellitus Type II p.m.a.r.p. was much higher in Austria as compared to the other countries, and these patients were indeed, as found in previous studies [14, 15, 18] , less likely to access the waiting list. Also, the incidence rate of RRT for ESKD due to diabetes mellitus Type I differs between the participating countries, with the highest rates in Scotland [19] . It is of interest to mention that the incidence of RRT p.m.a.r.p. 'without' patients with diabetes mellitus as primary renal disease was quite similar in the four participating countries under and above 65 years (Table 2 ). It should be noted that the criteria for the classification of diabetes mellitus Type I and Type II could differ between the participating countries. Furthermore, of all patients who started RRT, Norway had the highest proportion of patients on the waiting list. A reason for international differences in access to the waiting list could be that the Norwegian patients had less co-morbidity compared to the patients in the other participating countries [20] . However, we cannot exclude that that they were just as sick but were still on the waiting list.
Access to renal transplantation
The international variation in transplant rates may be due to a combination of factors, including legislation, availability of donors, transplant system organization and infrastructure, wealth and investment in health care as well as underlying public attitudes to and awareness of organ donation and transplantation [21] . The participating countries had different legislation with regard to organ donation. Austrian legislation, as in many other European countries, has adopted a system of 'presumed consent'. Under this system, everybody is presumed to consent to the donation of their organs when they die. Anyone can fill out a form saying they do not want to donate. In Norway, the Netherlands and Scotland, an informed consent is required in a voluntary system of organ donation whereby relatives give permission at the time of death, often in the knowledge that the deceased had expressed a wish to become a donor. Debate exists about the best legislation to promote the availability of deceased donor kidneys [22, 23] , and studies found that presumed consent may [24] or may not [25] be associated with higher organ deceased donation rates. Furthermore, results of a systematic review suggest that highest consent rates can be obtained if the request for donation does not occur at the same time as the notification of death [26] .
Different policies can be used to increase access to renal transplantation from deceased donors. For example, the high number of deceased donors in Austria (as in other countries such as Spain [5] ) is due to a proactive donor detection programme performed by well-trained transplant coordinators, the introduction of systematic death audits in hospitals and adequate economic reimbursement for the hospitals. Another opportunity to increase access to deceased donor kidneys is the allocation of controlled non-heart beating donors [27, 28] or the allocation of expanded criteria for donors [29] . For example, in the latter option, kidneys from older donors are allocated to older patients on the waiting list within the Eurotransplant Seniors Program in 1999 [28, 30] . The implementation of such strategies may represent a solution to increase the number of deceased donors in countries.
Some countries have different policies with regard to the promotion of living donation. In Norway, traditionally, living donation has been actively promoted and, as a result, transplant rates from living donors are higher than in other countries. An active transplantation program for living donation has increased the total number of living donors p.m.p. in many countries around the world [31, 32] . This trend was not observed in Norway during the study period where an active transplantation program promoting both deceased and living donation had been in place before the time frame of the present study. In contrast, Austria, the Netherlands and Scotland started an active transplantation programme on living donation later on and in these countries, the improvement in the access to living transplants occurred during the study period, although mainly in patients < 65 years of age. Ways to expand the pool of living donors have been explored. These include acceptance of genetically unrelated donors (kidney exchange), desensitization programmes for ABO incompatible pairs, cross match positive pairs and recognition or even promotion of anonymous (or non-anonymous) altruistic donation through indirect reward, such as lifelong exemption from medical insurance premiums [33] . It is, however, striking that our study showed that an increase in the number of transplants from living donors did not translate into an increase of the total number of transplants or to a substantial reduction of the median waiting time. One possible explanation is that the limited availability of deceased donors was the main driver of living donation, although some nephrologists are still hesitant regarding living donation.
As a result of the high number of kidney transplants from living donors and also of its relatively low RRT incidence, Norway was the only country that could transplant almost all patients on the waiting list below the age of 65 years within 4 years after the start of RRT. And even more strikingly, Norway succeeded also to transplant most of the older patients who were on the waiting list. Moreover, the median transplant waiting time was by far the shortest in Norway. Interestingly, a Norwegian study did not show a difference in the graft survival between older and younger patients when censored for death with a functioning graft [34] . Moreover, the results of a previous published study showed that in Norway, the survival after kidney transplantation in patients > 70 years of age has improved from 1995 to 2007 and offered a survival advantage over dialysis treatment [35] . Importantly, these results suggest that age is not a limitation per se for renal transplantation. Nevertheless, in contrast to Norway, the access to transplantation in older patients was low in Austria, the Netherlands and Scotland, although it doubled in Austria and the Netherlands from 1995 to 2003. This is in line with the results from a study from the USA [36] indicating that although only 7.3% of the patients who started RRT > 60 years from 2003 to 2006 received a renal transplant after 3 years, elderly patients were twice as likely to undergo transplantation in 2006
Access to the waiting list and renal transplantation 3629 compared to 1995. Nevertheless, the results from a study from the USA showed that almost half of the transplant candidates who were > 60 years of age and were on the kidney transplant waiting list die before receiving a deceased donor transplant [37] . It should be noted that because of the evolving transplant activities, the time trend in access to RRT, waiting list and kidney transplantation could be different after the study period.
Conclusions
The results from this study show that the number of available renal transplants did not parallel the increasing number of patients starting RRT > 65 years of age. Only in Norway, virtually all patients on the waiting list < 65 years received a transplant within 4 years after the start of RRT and, remarkably, also most of those > 65 years of age. This may be due to both their successful policy resulting in a high number of kidney transplants from both living and deceased donors and to their relatively low incidence of RRT. Although some of the other participating countries successfully maintained high transplant rates from deceased donors (Austria) or successfully increased the rates of transplant from living donors (the Netherlands), improved rates were mainly observed among patients < 65 years of age. Shortage of grafts from deceased donors remains a huge barrier to renal transplantation. For this reason, multiple strategies should be implemented by coordinated efforts of the medical community and health policy makers in order to increase transplants from both deceased and living donors. Only the promotion of such successful donation programmes holds promise for improving outcomes within the growing population with kidney disease.
